International Society of Glomerular Disease

Thank you @tobias-b-huber.bsky.social @yelenadrexlermd.bsky.social @alessiafornoni.bsky.social Dr Myda Khalid Dr Shikha Wadhwani Dr Barbara Gillespie Dr Margret Kamel Dr Jennifer McKenzie Dr Scott Wenderfer Dr Zubin J. Modi Dr Neha Pottanat Dr Pamela Winterberg Ashwini Roy-Chaudhury Angel Morales

ISGD Clinical Trial Bootcamp @ the ASPN-PNRC Fellows Workshop! 🩺🔬🌴 We’re bridging the research gap by: ✅ Equipping next-gen investigators ✅ Expanding the trial-ready workforce ✅ Making trials a standard of care
🔗 www.is-gd.org/time-to-trai... #Nephrology #ClinicalTrials #ISGD #PNRC

@utmbpresident.bsky.social @tobias-b-huber.bsky.social
@guptavi.bsky.social

🚀🌴💊 Early Bird Registration and abstract submissions are now OPEN for the 2026 ISGD Clinical Trials Summit in Galveston, TX! Join us in Nov. to advance innovative kidney research, find solutions to glomerular disease challenges, and shape the future of clinical trials. www.is-gd.org/cts-2026-reg...

Meet our Program Advisory Committee 🤩 Excited for what we’ll build together!

Jonathan Barratt
Hiddo Heerspink
Matthias Kretzler
Laura Mariani
Vlado Perkovic
Josh Tarnoff
Marina Vivarelli
Katherine Tuttle

2026 ISGD Clinical Trials Summit The 2026 ISGD Clinical Trials Innovation Summit will serve as a global hub for clinical trialists, nephrologists, and other stakeholders committed to transforming the future of kidney disease research...

Join our Clinical Trials Summit in Galveston, TX (Nov 13-15 2026) to advance innovative solutions in rare kidney disease trials. Registration & abstracts open Monday! www.is-gd.org/2026-cts @tobias-b-huber.bsky.social @utmbhealth.bsky.social Dr. Shikha Wadhwani
Dr. Jochen Reiser

A blue and purple promotional image for the "GN in Ten" podcast, featuring the International Society of Glomerular Disease logo. The text reads "Board Review Bonus #4: ANCA Vasculitis," and lists hosts Dr. Koyal Jain and Dr. Kenar Jhaveri. A stylized stopwatch icon is in the corner against a background of microscopic cellular structures.

🚨New GN in 10: Everything you need to know about ANCA Vasculitis🎙️

Join @kdjhaveri.bsky.social & Dr. Koyal Jain for a high-yield Board Review session covering all the basics and recent advances: share.transistor.fm/s/8be7fb84

#NephTwitter #MedEd #Vasculitis #BoardPrep @tobias-b-huber.bsky.social

The future of nephrology research is here! 🚀 ISGD Clinical Trial Bootcamps go global in 2026!

📍 Miami, Atlanta, Bordeaux & Mar de Plata.

🎟 Register for PNRC/RPA now: www.is-gd.org/time-to-train

#ISGD #ESPNSociety #PNRC @renalphysicians.bsky.social @alanepe.bsky.social @tobias-b-huber.bsky.social

ISGD Welcomes CMSO Barbara S. Gillespie Barbara Gillespie, MD, joins ISGD as Chief Medical and Strategy Officer to advance glomerular disease research, novel therapies, and key initiatives.

The International Society of Glomerular Disease is pleased to welcome Barbara Gillespie, MD, MMS, FASN, into the advisory role of Chief Medical and Strategy Officer! 🥳 @tobias-b-huber.bsky.social
www.is-gd.org/en/news-from...

Join ISGD Learn more about membership benefits and join the International Society of Glomerular Disease.

ASN has shown us the incredible advances being made in glomerular diseases and the opportunities we have to continue improving glomerular science, medicine, and patient care! Join the movement at www.is-gd.org/en/join-isgd
#ISGD #GlomerularDisease #ASNKidneyWeek2025 @tobias-b-huber.bsky.social

Post-ASN, the ISGD team visited Galveston and the UTMB campus and team! We chose the venue for the Inaugural 2026 ISGD Clinical Trials Summit. Please save the date: November 12-16, 2026. Stay tuned for more updates on this landmark event! #ClinicalTrials #ISGD @tobias-b-huber.bsky.social

🌐 Building Our Network - Our ASN reception was a massive success, bringing together over 200 people! It is amazing to see the network we have formed in under three years. It was fantastic to connect with so many of you. #ASN2025 #ISGD #KidneyWeek2025 @tobias-b-huber.bsky.social

Congrats to ISGD Members @ksusztak.bsky.social, @rkramann.bsky.social , Laura Mariani, and @genetickidneydoc.bsky.social on receiving major ASN awards! And congratulations to ISGD members who contributed to this year's amazing scientific content 💡#ISGD #KidneyWeek2025 @tobias-b-huber.bsky.social

ISGD had an impactful week at ASN 2025. Big Shout out to Matthias Kretzler ISGD Steering Committee Member and ASN Program Co-Chair, for his leadership in shaping the conference, and for keeping GD at the forefront
#ISGD #ASN2025 #GlomerularDisease #KidneyWeek2025 @tobias-b-huber.bsky.social

Importance of surrogate endpoints - focus on Proteinuria! @ASNKidney
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease

Oral Abstract Session 🌟
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease

Outstandining talk by @AstridWeins on anti-nephrin antibodies
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease

Innovative initiatives in Pediatric NS!
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease

Pediatric Nephrotic Syndrome Translational Session
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease

B-cell depleting strategies in lupus nephritis 🐺
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease

The role of B-cells in lupus nephritis by @AugustoVaglio 🐺
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease

Thrombotic microangiopathy in children - extensive differential @SethiRenalPath!
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease

Membranous Nephropathy is not Adult-exclusive #ASN2025!
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease

Yesterday's highlights: IgA Nephropathy at Plenary Session!
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease

Spreading the word about the Importance and Power of Podocytes at @asnkidney.bsky.social Kidney Week in Houston. @isgd.bsky.social

ASN begins with an inspiring speech from Dr. Prabir Roy-Chaudhury, ASN president. A standing ovation for the new landscape of clinical trials in GD. ISGD is on the ground and will be reporting on the latest in GD. Follow and join the conversation. #ASN2025 #GlomerularDisease

4 takeaways that renew our commitment to this community:
Voice: Include children in every discussion.
Train: Prepare the next generation of trialists
Collaborate: Link global groups, registries, & biobanks.
Equity: Progress must include all, especially in #LMICs.

What an inspiring week at ESPN 2025 in Athens! We’re energized by powerful conversations with pediatric nephrology experts from 57 countries, and grateful to the ESPN team for uniting our global community.

#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD

Flyer with following text: YOU’RE INVITED! Travere Therapeutics-Sponsored Webinar PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function Please use the link below to register Friday, October 24, 2025 12:00-1:00PM ET Join this not-to-be-missed webinar to hear from our speakers and panelists about: • The latest updates on the evolving IgA nephropathy treatment (IgAN) landscape, including discussion of the newly released 2025 KDIGO IgAN guidelines and their implications for optimized patient care • How achievement of proteinuria remission in IgAN can translate to preservation of kidney function • How clinical data and updated KDIGO recommendations support the foundational role of dual endothelin and angiotensin receptor antagonism with sparsentan in the treatment of IgAN MA-SP-25-0162 Official ISN Academy Webinar Registration link: https://bit.ly/47cZyX1

📣 Are you ready for the newest in IgAN?

Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."

Secure your spot: events.zoom.us/ev/AiBA7aMWF...

📢 A TSUNAMI of pediatric kidney clinical trials is upon us! 🌊

At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!

In the golden age of nephrology, no child will be left behind!